1. Home
  2. ICUI vs NHI Comparison

ICUI vs NHI Comparison

Compare ICUI & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • NHI
  • Stock Information
  • Founded
  • ICUI 1984
  • NHI 1991
  • Country
  • ICUI United States
  • NHI United States
  • Employees
  • ICUI N/A
  • NHI N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • NHI Real Estate Investment Trusts
  • Sector
  • ICUI Health Care
  • NHI Real Estate
  • Exchange
  • ICUI Nasdaq
  • NHI Nasdaq
  • Market Cap
  • ICUI 3.4B
  • NHI 3.3B
  • IPO Year
  • ICUI 1992
  • NHI 1991
  • Fundamental
  • Price
  • ICUI $133.44
  • NHI $71.55
  • Analyst Decision
  • ICUI Strong Buy
  • NHI Buy
  • Analyst Count
  • ICUI 5
  • NHI 5
  • Target Price
  • ICUI $196.75
  • NHI $84.60
  • AVG Volume (30 Days)
  • ICUI 215.9K
  • NHI 301.8K
  • Earning Date
  • ICUI 08-06-2025
  • NHI 08-05-2025
  • Dividend Yield
  • ICUI N/A
  • NHI 5.05%
  • EPS Growth
  • ICUI N/A
  • NHI 3.74
  • EPS
  • ICUI N/A
  • NHI 3.16
  • Revenue
  • ICUI $2,420,093,000.00
  • NHI $343,615,000.00
  • Revenue This Year
  • ICUI N/A
  • NHI $6.97
  • Revenue Next Year
  • ICUI N/A
  • NHI $10.70
  • P/E Ratio
  • ICUI N/A
  • NHI $22.60
  • Revenue Growth
  • ICUI 7.22
  • NHI 7.49
  • 52 Week Low
  • ICUI $117.92
  • NHI $65.13
  • 52 Week High
  • ICUI $196.26
  • NHI $86.13
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 50.47
  • NHI 50.50
  • Support Level
  • ICUI $129.26
  • NHI $69.52
  • Resistance Level
  • ICUI $139.41
  • NHI $72.06
  • Average True Range (ATR)
  • ICUI 4.24
  • NHI 1.29
  • MACD
  • ICUI 0.53
  • NHI 0.14
  • Stochastic Oscillator
  • ICUI 59.68
  • NHI 68.90

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Share on Social Networks: